Livingdiabetes

In this episode, we explore the dangerous intersection of diabetes and eating disorders, including the life-threatening condition diabulimia where insulin is deliberately restricted for weight loss. We discuss why people with diabetes are more vulnerable to disordered eating, warning signs that are often missed, binge eating disorder in type 2 diabetes, and why integrated care from specialists who understand both conditions produces the best outcomes. Follow us on social media for updates and more content.

In this episode, we examine whether GLP-1 medications like semaglutide and tirzepatide can affect mood and mental health. We explore the science behind GLP-1 receptors in the brain, review clinical trial and real-world evidence, discuss three mechanisms through which these medications could influence mood including direct CNS effects, psychological adjustment to appetite changes, and blood sugar fluctuations, and provide practical guidance for patients and prescribers. Follow us on social media for updates and more content.

In this special World Health Day episode, we look at the global scale of the diabetes epidemic with over 540 million adults affected worldwide. We examine geographic disparities, the insulin access crisis in low-income countries, the staggering economic burden exceeding 960 billion dollars, evidence-based prevention strategies, and the bright spots including national programmes and technology bridging gaps in care. Follow us on social media for updates and more content.

In this episode, we break down the critical difference between diabetes distress and clinical depression, two conditions that look similar but require completely different treatment approaches. We explain what diabetes distress actually is, how it differs from clinical depression, why the distinction matters for treatment decisions, and how validated screening tools like the Diabetes Distress Scale and PHQ-9 can help get the right diagnosis. Follow us on social media for updates and more content.

In this episode, we explore the science behind how stress hormones, particularly cortisol, directly raise blood sugar through multiple mechanisms including liver glucose release, increased insulin resistance, and chronic inflammation. We explain the hypothalamic-pituitary-adrenal axis, review clinical evidence linking stress to higher A1C values, and provide five practical strategies for managing stress as a core component of diabetes care. Follow us on social media for updates and more content.

In this episode, we explore amycretin, Novo Nordisk's oral dual agonist that targets both GLP-1 and amylin receptors in a single molecule. We break down how it differs from injectable options like CagriSema, review the impressive early trial data showing thirteen percent weight loss in just twelve weeks, discuss why an effective oral option matters for patient access, and look at where it fits in the evolving pipeline of diabetes and obesity medications. Follow us on social media for updates and more content.

In this episode, we look at CagriSema, a next-generation combination medication that pairs semaglutide with cagrilintide, an amylin analogue. We explain how this dual-pathway approach works, review the impressive phase three clinical trial results showing A1C reductions exceeding two percentage points and weight loss of fifteen to twenty percent, discuss the side effect profile, and explore when this medication might become available. Follow us on social media for updates and more content.

Welcome back to Living Diabetes. In this episode, we dive into the fundamental question of what diabetes is and what's happening inside your body. We explain how your body processes food, the role of glucose and insulin, and what goes wrong in diabetes. We also cover the symptoms and effects of high blood glucose levels, including frequent urination, excessive thirst, weight loss, and the dangers of diabetic ketoacidosis. Finally, we touch on the importance of managing blood glucose levels, setting blood glucose targets, and understanding the differences between type one and type two diabetes. Follow us on social media for updates and more content.

00:00 Introduction to Diabetes

00:19 How Your Body Processes Food

01:40 The Role of Insulin

02:47 What Happens When the System Fails

04:30 Symptoms and Body's Response

05:50 Managing Diabetes

06:22 Understanding the Causes

06:43 Addressing Common Misconceptions

07:18 Blood Glucose Targets

07:50 Conclusion and Next Steps

In this episode, we discuss the newly released Dietary Guidelines for Americans, which emphasise eating real food. The updated guidelines mark a significant shift from the old food pyramid from the 1990s, focusing on high-quality protein, vegetables, fruits, and healthy fats while reducing refined carbs and processed foods. Practical tips are provided to help you implement these changes in your daily diet. Follow us on social media for updates and more content.

In this episode, we unlock the potential to reverse type 2 diabetes, which could change lives forever!. We explore how recent medical research is reshaping our understanding of diabetes management. Gone are the days of seeing a diagnosis as a lifelong sentence. Discover the groundbreaking evidence that reveals type 2 diabetes can be controlled and, in many cases, even put into remission. 

We’ll discuss effective strategies, such as significant weight loss and dietary changes, that have shown remarkable results in various studies. If you or a loved one is affected by type 2 diabetes, this information could be life-altering. 

Join us on this journey of hope and healing! Don’t forget to like and share this video. 

#Type2Diabetes #DiabetesRemission #HealthJourney #DiabetesManagement #HopeForDiabetes

OUTLINE: 

00:00:00 Introduction to Type 2 Diabetes Remission

00:00:22 The Old View of Type 2 Diabetes

00:00:49 A New Perspective on Diabetes

00:01:10 The Possibility of Reversal

00:01:25 Challenging Conventional Wisdom

00:01:49 Understanding Diabetes Remission

00:02:15 The 'Great Big Lie'

00:02:36 Defining 'Reversing' Diabetes

00:03:10 The Possibility of Reversal

00:03:37 Achieving and Understanding Remission

00:04:05 Strategies for Remission

00:04:25 The DiRECT Trial

00:05:05 Additional Studies and Weight-Loss Surgery

00:05:26 The Science Behind Remission and Who Can Achieve It

00:05:32 The Twin-Cycle Hypothesis

00:06:01 Pancreatic Recovery

00:06:19 Factors Favoring Remission

00:06:41 Early Action is Key

00:06:52 A New Hope for the Future

00:07:18 Challenging Standard Treatment

00:07:36 A New Understanding

00:07:56 The Importance of Discussing Remission

00:08:10 Taking Control

00:08:31 End

Source:

1. Lean MEJ, Leslie WS, Barnes AC, et al. 5-year follow-up of the randomised Diabetes Remission Clinical Trial (DiRECT) of continued support for weight loss maintenance in the UK: an open-label, extension of a primary care-led, cluster-randomised trial. Lancet Diabetes Endocrinol. 2024;12(1):41–49.​
2. Gregson J, et al. Type 2 Diabetes Remission: A Systematic Review and Meta-analysis. Diabetes Care. 2025;48(12):2181–2192.